Scheduled Maintenance Notice

Please note that Researcher Profiles will be undergoing scheduled maintenance on Wednesday 7th Oct, from 8:00am to 9:00am. During this time, the Researcher Profiles system will be unavailable. We apologise for any inconvenience and appreciate your understanding.

Select Publications

Journal articles

Bird P; Hall S; Nash P; Connell CA; Kwok K; Witcombe D; Thirunavukkarasu K, 2019, 'Treatment outcomes in patients with seropositive versus seronegative rheumatoid arthritis in Phase III randomised clinical trials of tofacitinib', Rmd Open, 5, http://dx.doi.org/10.1136/rmdopen-2018-000742

Hall S; Nash P; Rischmueller M; Bossingham D; Bird P; Cook N; Witcombe D; Soma K; Kwok K; Thirunavukkarasu K, 2018, 'Tofacitinib, an Oral Janus Kinase Inhibitor: Pooled Efficacy and Safety Analyses in an Australian Rheumatoid Arthritis Population', Rheumatology and Therapy, 5, pp. 383 - 401, http://dx.doi.org/10.1007/s40744-018-0118-2

Nicholls D; Barrett R; Button P; Truman M; Bird P; Roberts L; Tymms K; Littlejohn G; Griffiths H, 2018, 'Effectiveness of biologics in Australian patients with rheumatoid arthritis: a large observational study: REAL', Internal Medicine Journal, 48, pp. 1185 - 1192, http://dx.doi.org/10.1111/imj.14028

Jones G; Hall S; Bird P; Littlejohn G; Tymms K; Youssef P; Chung E; Barrett R; Button P, 2018, 'A retrospective review of the persistence on bDMARDs prescribed for the treatment of rheumatoid arthritis in the Australian population', International Journal of Rheumatic Diseases, 21, pp. 1581 - 1590, http://dx.doi.org/10.1111/1756-185X.13243

Aitken D; Laslett LL; Pan F; Haugen IK; Otahal P; Bellamy N; Bird P; Jones G, 2018, 'A randomised double-blind placebo-controlled crossover trial of HUMira (adalimumab) for erosive hand OsteoaRthritis – the HUMOR trial', Osteoarthritis and Cartilage, 26, pp. 880 - 887, http://dx.doi.org/10.1016/j.joca.2018.02.899

Wells AF; Edwards CJ; Kivitz AJ; Bird P; Nguyen D; Paris M; Teng L; Aelion JA, 2018, 'Apremilast monotherapy in DMARD-naive psoriatic arthritis patients: Results of the randomized, placebocontrolled PALACE 4 trial', Rheumatology (United Kingdom), 57, pp. 1253 - 1263, http://dx.doi.org/10.1093/rheumatology/key032

Brown MA; Bird PA; Robinson PC; Mease PJ; Van Den Bosch F; Surian C; Jones H; Szumski A; Marshall L; Wiid Z; Dougados M, 2018, 'Evaluation of the effect of baseline MRI sacroiliitis and c reactive protein status on etanercept treatment response in non-radiographic axial spondyloarthritis: A post hoc analysis of the EMBARK study', Annals of the Rheumatic Diseases, 77, pp. 1090 - 1093, http://dx.doi.org/10.1136/annrheumdis-2017-211313

Benham GP; Castrejon-Pita AA; Hewitt IJ; Please CP; Style RW; Bird PAD, 2018, 'Turbulent shear layers in confining channels', Journal of Turbulence, 19, pp. 431 - 445, http://dx.doi.org/10.1080/14685248.2018.1459630

Tymms K; Littlejohn G; Griffiths H; de Jager J; Bird P; Joshua F; Nash P; Handel M; McManus H; Butcher BE; Youssef P, 2018, 'Treatment patterns among patients with rheumatic disease (rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA) and undifferentiated arthritis (UnA)) treated with subcutaneous TNF inhibitors', Clinical Rheumatology, 37, pp. 1617 - 1623, http://dx.doi.org/10.1007/s10067-018-4105-3

Dougados M; Fautrel BJ; Van De Laar MAFJ; Kirkham B; Alten R; Cseuz R; Smolen JS; Sanchez-Burson J; Bird P; Scheinberg M; Van Den Bosch F; Barry J; Durand F; Zhu B; De Leonardis F; Taylor PC, 2018, '226 Summary of baricitinib effect on patient-reported outcomes (PROs) in methotrexate-inadequate responder patient population', Rheumatology, 57, pp. key075.450, http://dx.doi.org/10.1093/rheumatology/key075.450

Mathew AJ; Bird P; Gupta A; George R; Danda D, 2018, 'Magnetic resonance imaging (MRI) of feet demonstrates subclinical inflammatory joint disease in cutaneous psoriasis patients without clinical arthritis', Clinical Rheumatology, 37, pp. 383 - 388, http://dx.doi.org/10.1007/s10067-017-3895-z

Bird P; Peterfy C; Countryman P; Griffiths H; Barrett R; Youssef P; Joshua F; Hall S, 2018, 'AC-CUTE: An Open-Label Study to Evaluate Progression of Structural Joint Damage and Inflammation in Subjects with Moderate to Severe Rheumatoid Arthritis', International Journal of Rheumatology, 2018, pp. 8721753, http://dx.doi.org/10.1155/2018/8721753

Tymms K; Kelly A; Bird P; Griffiths H; de Jager J; Littlejohn G; Louw S; Roberts L; Youssef P; Zochling J; Nichols D, 2018, 'Psoriatic arthritis treatment regimens, therapy duration and reasons for cessation in the biologics era: A multi-centre Australian study', International Journal of Rheumatic Diseases, 21, pp. 510 - 516, http://dx.doi.org/10.1111/1756-185X.13127

Benham GP; Hewitt IJ; Please CP; Bird PAD, 2018, 'Optimal control of diffuser shapes for non-uniform flow', Journal of Engineering Mathematics, 113, pp. 65 - 92, http://dx.doi.org/10.1007/s10665-018-9974-6

Bird P; Diamond T; Clark WA, 2017, 'Vertebroplasty for acute painful osteoporotic fracture', Medical Journal of Australia, 207, pp. 279 - 281.e1, http://dx.doi.org/10.5694/mja16.01423

Clark W; Bird P; DIamond T; Gonski P; Barnes E; Gebski V, 2017, 'Criticisms of the VAPOUR trial in a recent commentary are unsubstantiated and incorrect', Evidence Based Medicine, 22, pp. 116 - 117, http://dx.doi.org/10.1136/ebmed-2017-110737

Bird P; Nicholls D; Barrett R; de Jager J; Griffiths H; Roberts L; Tymms K; McCloud P; Littlejohn G, 2017, 'Longitudinal study of clinical prognostic factors in patients with early rheumatoid arthritis: the PREDICT study', International Journal of Rheumatic Diseases, 20, pp. 460 - 468, http://dx.doi.org/10.1111/1756-185X.13036

Smolen JS; Kremer JM; Gaich CL; Delozier AM; Schlichting DE; Xie L; Stoykov I; Rooney T; Bird P; Sánchez Bursón JM; Genovese MC; Combe B, 2017, 'Patient-reported outcomes from a randomised phase III study of baricitinib in patients with rheumatoid arthritis and an inadequate response to biological agents (RA-BEACON)', Annals of the Rheumatic Diseases, 76, pp. 694 - 700, http://dx.doi.org/10.1136/annrheumdis-2016-209821

Truong SL; Saad NF; Robinson PC; Cowderoy G; Lim I; Schachna L; Stebbings S; Stuckey S; Taylor AL; Whittle SL; Zochling J; Bird P; Brown MA, 2017, 'Consensus statements on the imaging of axial spondyloarthritis in Australia and New Zealand', Journal of Medical Imaging and Radiation Oncology, 61, pp. 58 - 69, http://dx.doi.org/10.1111/1754-9485.12573

Roberts L; Tymms K; De Jager J; Littlejohn G; Griffiths H; Nicholls D; Bird P; Young J; Hill J; Zochling J, 2017, 'The CEDAR Study: A longitudinal study of the clinical effects of conventional DMARDs and biologic DMARDs in Australian rheumatology practice', International Journal of Rheumatology, 2017, pp. 1201450, http://dx.doi.org/10.1155/2017/1201450

Aitken D; Pan F; Laslett L; Bellamy N; Bird P; Haugen I; Jones G, 2017, 'A randomised double-blind placebo-controlled crossover trial of humira (adalimumab) for erosive hand osteoarthritis: the humor trial', Osteoarthritis and Cartilage, 25, pp. s9, http://dx.doi.org/10.1016/j.joca.2017.02.032

Wells A; Edwards CJ; Kivitz A; Bird P; Nguyen D; Shah K; Lichen T; Lioté F; Pinton P; Aelion J, 2016, 'Apremilast monotherapy as the first systemic treatment in DMARD-naive patients with active psoriatic arthritis: 3-year treatment results', Revue Du Rhumatisme Edition Francaise, 83, pp. A249, http://dx.doi.org/10.1016/S1169-8330(16)30589-0

Kavanaugh A; Gladman D; Edwards CJ; Airi P; Lioté F; Bird P; Schett G; Nguyen D; Lichen T; Pinton P; Mease PJ, 2016, 'Apremilast, an oral phosphodiesterase 4 inhibitor, is associated with long-term (104-week) improvement in fatigue in patients with psoriatic arthritis: Pooled results from 3 Phase III, randomized, controlled trials', Revue Du Rhumatisme Edition Francaise, 83, pp. A248 - A249, http://dx.doi.org/10.1016/S1169-8330(16)30588-9

Edwards CJ; Blanco FJ; Crowley J; Birbara CA; Jaworski J; Aelion J; Stevens RM; Vessey A; Zhan X; Bird P, 2016, 'Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: A phase III, randomised, controlled trial (PALACE 3)', Annals of the Rheumatic Diseases, 75, pp. 1065 - 1073, http://dx.doi.org/10.1136/annrheumdis-2015-207963

Kavanaugh A; Gladman DD; Edwards CJ; Poder A; Lioté F; Bird P; Schett G; McIlraith M; Teng L; Mease PJ, 2016, '194 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, is Associated with Long-Term (104 Week) Improvement in Fatigue in Patients with Psoriatic Arthritis: Pooled Results from Three Phase III Randomized Controlled Trials', Rheumatology, 55, pp. i140 - i141, http://dx.doi.org/10.1093/rheumatology/kew145.005

Feletar M; Hall S; Bird P, 2016, 'Evaluation of magnetic resonance imaging responsiveness in active psoriatic arthritis at multiple timepoints during the first 12 weeks of antitumor necrosis factor therapy', Journal of Rheumatology, 43, pp. 75 - 80, http://dx.doi.org/10.3899/jrheum.150347

Nicholls D; Griffiths H; Barrett R; Button P; Truman M; Bird P; Roberts L; Tymms K; Littlejohn G, 2016, 'AB0344 A Retrospective Non-Interventional Study on The Use of Biologics in The Treatment of Australian Patients with Rheumatoid Arthritis-The Real Study', Annals of the Rheumatic Diseases, 75, pp. 1019 - 1020, http://dx.doi.org/10.1136/annrheumdis-2016-eular.4470

Bird P; Peterfy C; DiCarlo J; Joshua F; Hall S; Griffiths H; Youssef P; Barrett R; Button P, 2016, 'AB0368 AC-Cute: An Open-Label Study To Evaluate Non-Progression of Structural Joint Damage in Patients with Moderate To Severe Active Rheumatoid Arthritis Treated with Subcutaneous Tocilizumab', Annals of the Rheumatic Diseases, 75, pp. 1029 - 1030, http://dx.doi.org/10.1136/annrheumdis-2016-eular.3780

Glinatsi D; Bird P; Gandjbakhch F; Haavardsholm EA; Conaghan PG; Østergaard M; Group OBOTOMIAW, 2016, 'FRI0521 Reliability of An Omeract Rheumatoid Arthritis Tenosynovitis Scoring System for Wrist and Hand', Annals of the Rheumatic Diseases, 75, pp. 627 - 628, http://dx.doi.org/10.1136/annrheumdis-2016-eular.1445

Smerdely P; Bird P; Diamond T; Schlaphoff G; Gonski P, 2016, 'Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double-blind, placebo-controlled trial', Lancet, 388, pp. 1408 - 1408, http://dx.doi.org/10.1016/S0140-6736(16)31341-1

Wells AF; Edwards CJ; Kivitz AJ; Bird P; Nguyen D; Shah K; Teng L; Aelion JA, 2016, 'THU0422 Apremilast Monotherapy as The First Systemic Treatment in DMARD-Naïve Patients with Active Psoriatic Arthritis: 3-Year Treatment Results', Annals of the Rheumatic Diseases, 75, pp. 342, http://dx.doi.org/10.1136/annrheumdis-2016-eular.2405

Kavanaugh A; Gladman DD; Edwards CJ; Poder A; Lioté F; Bird P; Schett G; Nguyen D; Teng L; Mease PJ, 2016, 'THU0432 Apremilast, An Oral Phosphodiesterase 4 Inhibitor, Is Associated with Long-Term (104-Week) Improvement in Fatigue in Patients with Psoriatic Arthritis: Pooled Results from 3 Phase III, Randomized, Controlled Trials', Annals of the Rheumatic Diseases, 75, pp. 346, http://dx.doi.org/10.1136/annrheumdis-2016-eular.1487

Nicholls D; Nakayama A; Griffiths H; Littlejohn G; Bird P; Roberts L; de Jager J; Zochling J; Richter S; Louw S; Tymms K; Consortium OBOTO, 2016, 'THU0436 A Retrospective Non-Interventional Multi-Centre Study Evaluating Treatment Regimens Used in Psoriatic Arthritis Patients in Australia- The PSA Real Study', Annals of the Rheumatic Diseases, 75, pp. 348, http://dx.doi.org/10.1136/annrheumdis-2016-eular.2099

Boughton H; Zhang M; Powley W; Martin P; Bird P; Horman R, 2016, 'Using economic models to capture importance policy for tuning in autonomic database management systems', International Journal of Autonomic Computing, 2, pp. 114, http://dx.doi.org/10.1504/ijac.2016.082027

Bird P; Martin P; Zhang M; Powley W; Horman R; Boughton H, 2016, 'Using economic models to capture importance policy for tuning in autonomic database management systems', International Journal of Autonomic Computing, 2, pp. 114, http://dx.doi.org/10.1504/ijac.2016.10002935

Haugen IK; Eshed I; Gandjbakhch F; Foltz V; Østergaard M; Bøyesen P; Bird P; Genant HK; Peterfy CG; Conaghan PG, 2015, 'The longitudinal reliability and responsiveness of the OMERACT Hand Osteoarthritis Magnetic Resonance Imaging Scoring System (HOAMRIS)', Journal of Rheumatology, 42, pp. 2486 - 2491, http://dx.doi.org/10.3899/jrheum.140983

Østergaard M; Bird P; Gandjbakhch F; Eshed I; Haugen IK; Haavardsholm EA; Lillegraven S; Foltz V; Glinatsi D; Peterfy C; Ejbjerg B; Bøyesen P; Mease PJ; Hermann KG; Emery P; Genant HK; Conaghan PG, 2015, 'The OMERACT MRI in arthritis working group - Update on status and future research priorities', Journal of Rheumatology, 42, pp. 2470 - 2472, http://dx.doi.org/10.3899/jrheum.141248

Glinatsi D; Lillegraven S; Haavardsholm EA; Eshed I; Conaghan PG; Peterfy C; Gandjbakhch F; Bird P; Bøyesen P; Døhn UM; Genant HK; Østergaard M, 2015, 'Validation of the OMERACT magnetic resonance imaging joint space narrowing score for the wrist in a multireader longitudinal trial', Journal of Rheumatology, 42, pp. 2480 - 2485, http://dx.doi.org/10.3899/jrheum.141009

Glinatsi D; Bird P; Gandjbakhch F; Mease PJ; Bøyesen P; Peterfy CG; Conaghan PG; Østergaard M, 2015, 'Validation of the OMERACT Psoriatic Arthritis Magnetic Resonance Imaging Score (PsAMRIS) for the hand and foot in a randomized placebo-controlled trial', Journal of Rheumatology, 42, pp. 2473 - 2479, http://dx.doi.org/10.3899/jrheum.141010

Littlejohn G; Roberts L; Bird P; De Jager J; Griffiths H; Nicholls D; Young J; Zochling J; Tymms KE, 2015, 'Patients with rheumatoid arthritis in the Australian OPAL cohort show significant improvement in disease activity over 5 years: A multicenter observational study', Journal of Rheumatology, 42, pp. 1603 - 1609, http://dx.doi.org/10.3899/jrheum.141575

Mathew AJ; Bird P, 2015, 'Utility of in-office extremity magnetic resonance imaging in rheumatology', Indian Journal of Rheumatology, 10, pp. 140 - 146, http://dx.doi.org/10.1016/j.injr.2015.06.002

Clark W; Bird P; Diamond T; Gonski P, 2015, 'Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): Study protocol for a randomized controlled trial', Trials, 16, http://dx.doi.org/10.1186/s13063-015-0671-8

Brown MA; Bird PA; Robinson PC; Mease P; van den Bosch F; Surian C; Wiid Z; Jones H; Szumski A; Marshall L, 2015, 'SAT0258 Baseline MRI/CRP as Predictors of Response to Etanercept in the Management of Patients with Non-Radiographic Axial Spondyloarthritis', Annals of the Rheumatic Diseases, 74, pp. 752, http://dx.doi.org/10.1136/annrheumdis-2015-eular.2254

Wells A; Edwards C; Adebajo A; Kivitz A; Bird P; Shah K; Hu C; Aelion J, 2015, 'SAT0562 Long-Term (104-Week) Efficacy and Safety of Apremilast Monotherapy in Dmard-Naïve Patients with Psoriatic Arthritis: A Phase 3, Randomized, Controlled Trial and Open-Label Extension (Palace 4)', Annals of the Rheumatic Diseases, 74, pp. 863 - 864, http://dx.doi.org/10.1136/annrheumdis-2015-eular.2896

Bowes MA; Guillard G; Vincent GR; Hensor EM; Bird P; Freeston JE; Vital EM; Emery P; Conaghan PG, 2015, 'SAT0585 Can we Stop Using Contrast in RA MRI Clinical Trials? Quantitative MRI Demonstrates Similar Responsiveness for Contrast and Contrast-Free Synovitis Assessment', Annals of the Rheumatic Diseases, 74, pp. 873, http://dx.doi.org/10.1136/annrheumdis-2015-eular.4884

Roberts C; Guillard G; Bowes MA; O'Connor R; Maguire N; Morgan A; Parker GJ; Hodgson R; Vital EM; Bird P; Vincent GR; Emery P; Conaghan PG, 2015, 'SAT0601 A Novel, Fully 3-Dimensional Dynamic Contrast MRI Method in the Hand Reveals Details of Synovial Inflammation and Provides a Sensitive Measure of Change', Annals of the Rheumatic Diseases, 74, pp. 879, http://dx.doi.org/10.1136/annrheumdis-2015-eular.6400

McInnes IB; Mease PJ; Kirkham B; Kavanaugh A; Ritchlin CT; Rahman P; van der Heijde D; Landewé R; Conaghan PG; Gottlieb AB; Richards H; Pricop L; Ligozio G; Patekar M; Mpofu S; Group F2S, 2015, 'Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial', The Lancet, 386, pp. 1137 - 1146, http://dx.doi.org/10.1016/s0140-6736(15)61134-5

Jones G; Bird P; Hall S; Littlejohn G; Tymms K; Youssef P; Chung E; Bennett C; Button P, 2015, 'THU0146 Dispensing of Biologics Prescribed for the Treatment of Rheumatoid Arthritis in the Australian Population', Annals of the Rheumatic Diseases, 74, pp. 246 - 247, http://dx.doi.org/10.1136/annrheumdis-2015-eular.4326

Wong PKK; Christie L; Johnston J; Bowling A; Freeman D; Joshua F; Bird P; Chia K; Bagga H, 2014, 'How well do patients understand written instructions?: Health literacy assessment in rural and urban rheumatology outpatients', Medicine United States, 93, http://dx.doi.org/10.1097/MD.0000000000000129

Poggenborg RP; Wiell C; Bøyesen P; Boonen A; Bird P; Pedersen SJ; Sørensen IJ; Madsen OR; Slot O; Møller JM; Hasselquist M; Kubassova O; østergaard M, 2014, 'No overall damage progression despite persistent inflammation in adalimumab-treated psoriatic arthritis patients: Results from an investigator-initiated 48-week comparative magnetic resonance imaging, computed tomography and radiography trial', Rheumatology United Kingdom, 53, pp. 746 - 756, http://dx.doi.org/10.1093/rheumatology/ket426


Back to profile page